As of Jan 23
| -0.20 / -1.27%|
The 1 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +156.41% increase from the last price of 15.60.
The current consensus among 1 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.